Frazier Life Sciences Management, L.P. Kal Vista Pharmaceuticals, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.9 Billion
- Q1 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 3,687,867 shares of KALV stock, worth $43 Million. This represents 2.3% of its overall portfolio holdings.
Number of Shares
3,687,867
Previous 3,622,294
1.81%
Holding current value
$43 Million
Previous $44.4 Million
1.43%
% of portfolio
2.3%
Previous 2.73%
Shares
4 transactions
Others Institutions Holding KALV
# of Institutions
131Shares Held
46.5MCall Options Held
113KPut Options Held
72K-
Vr Adviser, LLC New York, NY6.25MShares$72.9 Million6.36% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.19MShares$48.9 Million2.13% of portfolio
-
Tang Capital Management LLC San Diego, CA4.13MShares$48.1 Million5.96% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.58MShares$30.1 Million0.06% of portfolio
-
Black Rock Inc. New York, NY2.43MShares$28.4 Million0.0% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $287M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...